Recall one batche of Zicarb-200 (Dacarbazine)
2025-02-25
الاسم التجاري الاسم العلمي رقم التسجيل رقم التشغيلة المتأثرة الشركة الصانعة Trade Name Scientific Name Register Number Affected batch number Manufacturer Zicarb-200 (Dacarbazine) Dacarbazine Not registered 1426018 NEON LABORATORIES LIMITED
التصنيف
ملف
التاريخ
2025-02-23
اسم المستحضر
Zicarb-200 (Dacarbazine)
اجراء الاستدعاء
مستوى الاستدعاء
نوع المستحضر
سبب السحب
SFDA has issued a recall of one batche of Zicarb-200 tablet due to the product incompliance with the requirements of the executive regulations for the Pharmaceutical establishments system.
التوصيات
For healthcare professionals: Stop dispensing the affected batche immediately. Embargo/Quarantine all remaining stock. Affected batches should be returned to the supplier.
For patients,
- Consult your healthcare provider prior to discontinuing use of the affected batche, or for any health concerns.
- Contact the recalling firm or SFDA if you have any questions about the recall.
- Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。